EKF Diagnostics Holdings PLC EKF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX 27.80
- Day Range
- GBX 27.60–28.45
- 52-Week Range
- GBX 22.20–60.00
- Bid/Ask
- GBX 0.00 / GBX 0.00
- Market Cap
- GBX 12.52 Bil
- Volume/Avg
- 82,356 / 309,486
Key Statistics
- Price/Earnings (Normalized)
- 63.63
- Price/Sales
- 2.40
- Dividend Yield (Trailing)
- 4.32%
- Dividend Yield (Forward)
- —
- Total Yield
- 4.32%
Company Profile
EKF Diagnostics Holdings PLC is engaged in the field of medical diagnostics. The company's core business is point-of-care testing and manufacturing reagents for use in central laboratories. It caters to companies focused on areas such as diabetes, blood banking, and sports medicine. The company derives its income from its sales in the United States. Its other markets include Germany, Poland, and Russia.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.ekfdiagnostics.com
Comparables
Valuation
|
Metric
|
EKF
|
IDHC
|
300482
|
|---|---|---|---|
Price/Earnings (Normalized) | 63.63 | 13.20 | 34.91 |
Price/Book Value | 1.88 | 2.12 | 2.62 |
Price/Sales | 2.40 | 1.54 | 3.93 |
Price/Cash Flow | 17.15 | 8.00 | 20.66 |
Price/Earnings
EKF
IDHC
300482
Financial Strength
|
Metric
|
EKF
|
IDHC
|
300482
|
|---|---|---|---|
Quick Ratio | 1.53 | 1.21 | 7.84 |
Current Ratio | 2.69 | 1.54 | 9.07 |
Interest Coverage | 27.75 | 5.69 | 14.34 |
Quick Ratio
EKF
IDHC
300482
Profitability
|
Metric
|
EKF
|
IDHC
|
300482
|
|---|---|---|---|
Return on Assets (Normalized) | 6.17% | 8.36% | 4.38% |
Return on Equity (Normalized) | 7.61% | 16.54% | 5.88% |
Return on Invested Capital (Normalized) | 7.21% | 14.60% | 5.54% |
Return on Assets
EKF
IDHC
300482
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Nvptyqpym | Cbpkqm | $185.4 Bil | |
SYK
| Stryker Corp | Qhspqrrfp | Gmpv | $128.2 Bil | |
BSX
| Boston Scientific Corp | Xvppphl | Bsfhjcs | $107.7 Bil | |
MDT
| Medtronic PLC | Fcfkpmww | Tvwpnt | $105.2 Bil | |
DXCM
| DexCom Inc | Vfdmchqdq | Mybm | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Hxyfvhwwyh | Ptdfx | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Vqsybpmff | Hrp | $24.6 Bil | |
ALGN
| Align Technology Inc | Nwlpzbf | Vxvtbs | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Thbwrqzgp | Jscxxz | $18.7 Bil | |
PODD
| Insulet Corp | Xnkjxppmn | Xxrjyzs | $11.5 Bil |